David MacNaughtan

Private Equity Investor at

Canada Pension Plan Investment Board Private Investments

59 year

66 connections

Finance

Health Technology

Consumer Services

Profile

David MacNaughtan is currently a Senior Principal at Canada Pension Plan Investment Board Private Investments, a Partner at Sagard Holdings ULC, and the Partner & Head of Sagard Royalty Partners at Sagard Healthcare Royalties.
He previously worked as a Director at Isotechnika Pharma, Inc., a Director at Jaguar Health, Inc., and as the Executive VP & Co-Head-Royalty Monetization Fund at DRI Capital, Inc. He also served as the Vice President-Business Development at Paladin Labs, Inc. and as an Investment Manager at Royal Bank Capital Corp.
Mr. MacNaughtan holds an MBA from Rotman School of Management and both undergraduate and graduate degrees from Queen's University.

David MacNaughtan active positions

Companies	Position	Start
Canada Pension Plan Investment Board Private Investments Canada Pension Plan Investment Board Private Investments Investment ManagersFinance CPPIB Private Investments invests in middle market companies located across the globe primarily in China, Japan, Korea, India, SE Asia and Australia. The firm focuses on technology, healthcare, industrials and service sectors. It provides financing for buyout, secondaries and growth capital requirements with an investment size of more than CAD 500 million. It acquires minority interest and also makes co-investments.	Private Equity Investor	11/01/2011
Sagard Holdings ULC Sagard Holdings ULC Investment ManagersFinance Provides alternative asset management services	Corporate Officer/Principal	01/12/2018
Sagard Healthcare Royalties Sagard Healthcare Royalties Investment ManagersFinance Functions as an alternative investment manager	Private Equity Investor	01/01/2019

All active positions of David MacNaughtan

Former positions of David MacNaughtan

Companies	Position	End
JAGUAR HEALTH, INC.	Director/Board Member	21/02/2020
PALADIN LABS INC.	Corporate Officer/Principal	01/09/2002
Royal Bank Capital Corp.	Corporate Officer/Principal	01/08/1999
DRI Healthcare DRI Healthcare Investment ManagersFinance DRI Healthcare invests in royalty interests in leading pharmaceutical and biotechnology companies, research institutions, universities and inventors.	Corporate Officer/Principal	-
Isotechnika Pharma, Inc. Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics	Director/Board Member	-

See the detail of David MacNaughtan's experience

Training of David MacNaughtan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David MacNaughtan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
DRI Healthcare DRI Healthcare Investment ManagersFinance DRI Healthcare invests in royalty interests in leading pharmaceutical and biotechnology companies, research institutions, universities and inventors.	Finance
Paladin Labs, Inc. Paladin Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceuticals	Health Technology
Rotman School of Management Rotman School of Management Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Queen's University Queen's University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Canada Pension Plan Investment Board Private Investments Canada Pension Plan Investment Board Private Investments Investment ManagersFinance CPPIB Private Investments invests in middle market companies located across the globe primarily in China, Japan, Korea, India, SE Asia and Australia. The firm focuses on technology, healthcare, industrials and service sectors. It provides financing for buyout, secondaries and growth capital requirements with an investment size of more than CAD 500 million. It acquires minority interest and also makes co-investments.	Finance
Isotechnika Pharma, Inc. Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics	Health Technology
Royal Bank Capital Corp.
Jaguar Health, Inc. Jaguar Health, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals	Health Technology
Sagard Holdings ULC Sagard Holdings ULC Investment ManagersFinance Provides alternative asset management services	Finance
Sagard Healthcare Royalties Sagard Healthcare Royalties Investment ManagersFinance Functions as an alternative investment manager	Finance